查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1654208

中风治疗市场规模、份额、趋势分析报告：按药物类别、类型、分销管道、地区、细分预测，2025-2030 年

Cerebral Infarction Treatment Market Size, Share & Trends Analysis Report By Drug Class (Anticoagulants, Antiplatelets), By Type (Ischemic Stroke), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

中风治疗市场的成长与趋势：

根据Grand View Research, Inc.的最新报告，全球中风治疗市场预计到2030年将达到205.1亿美元，2025年至2030年期间的复合年增长率为7.4%。

全球人口老化导致缺血性中风盛行率不断上升以及高血压、糖尿病等生活方式相关风​​险因素的增加是推动中风治疗市场扩大的主要因素。

根据美国国家医学图书馆2023年3月发表的研究，出血性中风每年占所有中风的10.0%至20.0%。不同地区的发生率差异很大，美国、英国和澳洲的发生率为 8.0% 至 15.0%，日本和韩国的发生率为 18.0% 至 24.0%。出血性中风的发生率在中低收入国家和亚洲人群中明显较高。此外，男性中风发生率较高，且随着年龄的增长而增加，而全球出血性中风的负担正在增加，尤其是在非洲和亚洲国家。研究表明，有效的高血压管理可以降低脑出血 (ICH) 的发病率，但死亡率仍然令人担忧，高所得国家的死亡率为 25.0-30.0%，低收入地区的死亡率为 30-48%，突显了重症加护效果的差异。

技术进步显着提高了中风治疗的现状。组织型胞浆素原原激活剂（tPA）等血栓溶解疗法的创新以及机械血栓切除装置的开发显着改善了患者的治疗效果。此外，人工智慧（AI）融入诊断和治疗过程正在彻底改变中风护理。人工智慧主导的演算法现在在预测中风风险和製定治疗策略方面发挥关键作用，有助于个人化治疗并提高其整体有效性。这些进步不仅提高了治疗的精准度，也促进了先进治疗方法的广泛应用。这些技术进步加上不断增加的研发投入预计将推动中风治疗市场的显着成长。

中风治疗市场报告重点

  • 2024 年，缺血性中风因其高盛行率、技术进步以及对早期疗育的认识不断提高而占最大份额，为 78.6%。
  • 组织胞浆素原激活剂 (tPA) 领域预计将在 2024 年获得 39.2% 的最大收益占有率，这得益于其被证实的有效性、广泛的用途以及在缺血性中风治疗中的关键作用。
  • 2024 年，医院药局部门将主导中风治疗市场，占 63.6% 的显着销售份额。

目录

第一章调查方法与范围

第 2 章执行摘要

中风治疗市场变数、趋势与范围

  • 市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 商业环境分析
    • 产业分析-波特五力分析
    • PESTLE分析

中风治疗市场：药物类别业务分析

  • 2024 年及 2030 年药物类别市场占有率
  • 药品类别细分仪表板
  • 2018 年至 2030 年按药物类别分類的市场规模、预测和趋势分析
  • 组织胞浆素原原激活剂 (tPA)
  • 抗凝血剂
  • 抗血小板药物
  • 抗惊厥药
  • 其他的

第 5 章中风治疗市场：按类型分類的业务分析

  • 2024 年及 2030 年各类型市场占有率
  • 类型细分仪表板
  • 2018 年至 2030 年按类型分類的市场规模、预测与趋势分析
  • 缺血性中风
  • 出血性中风

中风治疗市场：通路业务分析

  • 分销通路市场占有率，2024 年和 2030 年
  • 分销通路细分仪表板
  • 2018 年至 2030 年按分销管道分類的市场规模、预测和趋势分析
  • 医院药房
  • 零售药局
  • 其他的

第 7 章中风治疗市场：按地区分類的估计和趋势分析

  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 2018 年至 2030 年市场规模及预测趋势分析：
  • 北美洲
    • 按国家
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 按国家
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 按国家
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 按国家
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 参与者概述
  • 企业市场分析
  • 公司分类
  • 战略地图
  • 公司简介/上市公司
    • Amgen Inc.
    • Pfizer Inc.
    • Novartis AG
    • Amneal Pharmaceuticals LLC
    • Sanofi
    • Abbott
    • Johnson &Johnson Services, Inc.
    • Bristol-Myers Squibb Company
    • DAIICHI SANKYO COMPANY
    • Otsuka Holdings Co., Ltd.
Product Code: GVR-4-68040-450-8

Cerebral Infarction Treatment Market Growth & Trends:

The global cerebral infarction treatment market size is expected to reach USD 20.51 billion by 2030 and is projected to grow at a CAGR of 7.4% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growing prevalence of ischemic strokes, driven by an aging global population and increasing rates of lifestyle-related risk factors such as hypertension and diabetes, is a key factor in the expansion of the cerebral infarction treatment market.

According to a study published by the National Library of Medicine in March 2023, hemorrhagic stroke accounts for 10.0% to 20.0% of all strokes annually. The incidence varies significantly by region, with 8.0%-15.0% in the U.S., the UK, and Australia, and 18.0% to 24.0% in Japan and Korea. The rate of hemorrhagic stroke is notably higher in low- and middle-income countries, and among Asians. Furthermore, while stroke incidence is higher in men and increases with age, the global burden of hemorrhagic stroke is rising, particularly in African and Asian countries. Effective management of hypertension has been shown to reduce the incidence of intracerebral hemorrhage (ICH), though the fatality rate remains a concern, ranging from 25.0% to 30.0% in high-income countries and 30% to 48% in lower-income regions, highlighting disparities in critical care efficacy.

Technological advancements are significantly enhancing the treatment landscape for cerebral infarction. Innovations in thrombolytic therapies, such as tissue plasminogen activators (tPA), and development of mechanical thrombectomy devices have markedly improved patient outcomes. Moreover, the integration of artificial intelligence (AI) into diagnostic and treatment processes is revolutionizing stroke care. AI-driven algorithms now play a crucial role in predicting stroke risk and tailoring treatment strategies, which helps in personalizing care and improving overall efficacy. These advancements are not only improving the precision of treatments but also contributing to the broader adoption of advanced therapeutic options. Combined with increased investment in research and development, these technological strides are expected to drive significant growth in the cerebral infarction treatment market.

Cerebral Infarction Treatment Market Report Highlights:

  • In 2024, the ischemic stroke segment held the largest share of 78.6% due to its high prevalence, technological advancements, and growing awareness of early intervention
  • The tissue plasminogen activators (tPA) segment secured the largest revenue share of 39.2% in 2024, driven by its proven efficacy, widespread use, and crucial role in treating ischemic strokes
  • In 2024, the hospital pharmacies segment dominated the cerebral infarction treatment market, capturing a substantial revenue share of 63.6%

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Drug Class
    • 1.2.2. Type
    • 1.2.3. Distribution Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Cerebral Infarction Treatment Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Cerebral Infarction Treatment Market: Drug Class Business Analysis

  • 4.1. Drug Class Market Share, 2024 & 2030
  • 4.2. Drug Class Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Drug Class, 2018 to 2030 (USD Billion)
  • 4.4. Tissue Plasminogen Activators (tPA)
    • 4.4.1. Tissue Plasminogen Activators (tPA) Market, 2018 - 2030 (USD Billion)
  • 4.5. Anticoagulants
    • 4.5.1. Anticoagulants Market, 2018 - 2030 (USD Billion)
  • 4.6. Antiplatelets
    • 4.6.1. Antiplatelets Market, 2018 - 2030 (USD Billion)
  • 4.7. Anticonvulsants
    • 4.7.1. Anticonvulsants Market, 2018 - 2030 (USD Billion)
  • 4.8. Others
    • 4.8.1. Others Market, 2018 - 2030 (USD Billion)

Chapter 5. Cerebral Infarction Treatment Market: Type Business Analysis

  • 5.1. Type Market Share, 2024 & 2030
  • 5.2. Type Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Billion)
  • 5.4. Ischemic Stroke
    • 5.4.1. Ischemic Stroke Market, 2018 - 2030 (USD Billion)
  • 5.5. Hemorrhagic Stroke
    • 5.5.1. Hemorrhagic Stroke Market, 2018 - 2030 (USD Billion)

Chapter 6. Cerebral Infarction Treatment Market: Distribution Channel Business Analysis

  • 6.1. Distribution Channel Market Share, 2024 & 2030
  • 6.2. Distribution Channel Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Billion)
  • 6.4. Hospital Pharmacies
    • 6.4.1. Hospital Pharmacies Market, 2018 - 2030 (USD Billion)
  • 6.5. Retail Pharmacies
    • 6.5.1. Retail Pharmacies Market, 2018 - 2030 (USD Billion)
  • 6.6. Other
    • 6.6.1. Other Market, 2018 - 2030 (USD Billion)

Chapter 7. Cerebral Infarction Treatment Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. North America Cerebral Infarction Treatment Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework
      • 7.4.2.3. Competitive Insights
      • 7.4.2.4. U.S. Cerebral Infarction Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework
      • 7.4.3.3. Competitive Insights
      • 7.4.3.4. Canada Cerebral Infarction Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Regulatory Framework
      • 7.4.4.3. Competitive Insights
      • 7.4.4.4. Mexico Cerebral Infarction Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.5. Europe
    • 7.5.1. Europe Cerebral Infarction Treatment Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework
      • 7.5.2.3. Competitive Insights
      • 7.5.2.4. UK Cerebral Infarction Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework
      • 7.5.3.3. Competitive Insights
      • 7.5.3.4. Germany Cerebral Infarction Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Framework
      • 7.5.4.3. Competitive Insights
      • 7.5.4.4. France Cerebral Infarction Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory Framework
      • 7.5.5.3. Competitive Insights
      • 7.5.5.4. Italy Cerebral Infarction Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory Framework
      • 7.5.6.3. Competitive Insights
      • 7.5.6.4. Spain Cerebral Infarction Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.7. Denmark
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Regulatory Framework
      • 7.5.7.3. Competitive Insights
      • 7.5.7.4. Denmark Cerebral Infarction Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.8. Sweden
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Regulatory Framework
      • 7.5.8.3. Competitive Insights
      • 7.5.8.4. Sweden Cerebral Infarction Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Regulatory Framework
      • 7.5.9.3. Competitive Insights
      • 7.5.9.4. Norway Cerebral Infarction Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Cerebral Infarction Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework
      • 7.6.2.3. Competitive Insights
      • 7.6.2.4. Japan Cerebral Infarction Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework
      • 7.6.3.3. Competitive Insights
      • 7.6.3.4. China Cerebral Infarction Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework
      • 7.6.4.3. Competitive Insights
      • 7.6.4.4. India Cerebral Infarction Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework
      • 7.6.5.3. Competitive Insights
      • 7.6.5.4. South Korea Cerebral Infarction Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.6. Australia
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Framework
      • 7.6.6.3. Competitive Insights
      • 7.6.6.4. Australia Cerebral Infarction Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Regulatory Framework
      • 7.6.7.3. Competitive Insights
      • 7.6.7.4. Thailand Cerebral Infarction Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.7. Latin America
    • 7.7.1. Latin America Cerebral Infarction Treatment Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Framework
      • 7.7.2.3. Competitive Insights
      • 7.7.2.4. Brazil Cerebral Infarction Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Framework
      • 7.7.3.3. Competitive Insights
      • 7.7.3.4. Argentina Cerebral Infarction Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.8. MEA
    • 7.8.1. MEA Cerebral Infarction Treatment Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Framework
      • 7.8.2.3. Competitive Insights
      • 7.8.2.4. South Africa Cerebral Infarction Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Framework
      • 7.8.3.3. Competitive Insights
      • 7.8.3.4. Saudi Arabia Cerebral Infarction Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Framework
      • 7.8.4.3. Competitive Insights
      • 7.8.4.4. UAE Cerebral Infarction Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Regulatory Framework
      • 7.8.5.3. Competitive Insights
      • 7.8.5.4. Kuwait Cerebral Infarction Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Amgen Inc.
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. Pfizer Inc.
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Novartis AG
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Amneal Pharmaceuticals LLC
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Sanofi
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Abbott
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. Johnson & Johnson Services, Inc.
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. Bristol-Myers Squibb Company
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. DAIICHI SANKYO COMPANY
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. Otsuka Holdings Co., Ltd.
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global cerebral infarction treatment market, by region, 2018 - 2030 (USD Billion)
  • Table 4 Global cerebral infarction treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 5 Global cerebral infarction treatment market, by type, 2018 - 2030 (USD Billion)
  • Table 6 Global cerebral infarction treatment market, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 7 North America cerebral infarction treatment market, by country, 2018 - 2030 (USD Billion)
  • Table 8 North America cerebral infarction treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 9 North America cerebral infarction treatment market, by type, 2018 - 2030 (USD Billion)
  • Table 10 North America cerebral infarction treatment market, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 11 U.S. cerebral infarction treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 12 U.S. cerebral infarction treatment market, by type, 2018 - 2030 (USD Billion)
  • Table 13 U.S. cerebral infarction treatment market, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 14 Canada cerebral infarction treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 15 Canada cerebral infarction treatment market, by type, 2018 - 2030 (USD Billion)
  • Table 16 Canada cerebral infarction treatment market, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 17 Mexico cerebral infarction treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 18 Mexico cerebral infarction treatment market, by type, 2018 - 2030 (USD Billion)
  • Table 19 Mexico cerebral infarction treatment market, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 20 Europe cerebral infarction treatment market, by country, 2018 - 2030 (USD Billion)
  • Table 21 Europe cerebral infarction treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 22 Europe cerebral infarction treatment market, by type, 2018 - 2030 (USD Billion)
  • Table 23 Europe cerebral infarction treatment market, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 24 UK cerebral infarction treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 25 UK cerebral infarction treatment market, by type, 2018 - 2030 (USD Billion)
  • Table 26 UK cerebral infarction treatment market, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 27 Germany cerebral infarction treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 28 Germany cerebral infarction treatment market, by type, 2018 - 2030 (USD Billion)
  • Table 29 Germany cerebral infarction treatment market, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 30 France cerebral infarction treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 31 France cerebral infarction treatment market, by type, 2018 - 2030 (USD Billion)
  • Table 32 France cerebral infarction treatment market, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 33 Italy cerebral infarction treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 34 Italy cerebral infarction treatment market, by type, 2018 - 2030 (USD Billion)
  • Table 35 Italy cerebral infarction treatment market, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 36 Spain cerebral infarction treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 37 Spain cerebral infarction treatment market, by type, 2018 - 2030 (USD Billion)
  • Table 38 Spain cerebral infarction treatment market, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 39 Denmark cerebral infarction treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 40 Denmark cerebral infarction treatment market, by type, 2018 - 2030 (USD Billion)
  • Table 41 Denmark cerebral infarction treatment market, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 42 Sweden cerebral infarction treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 43 Sweden cerebral infarction treatment market, by type, 2018 - 2030 (USD Billion)
  • Table 44 Sweden cerebral infarction treatment market, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 45 Norway cerebral infarction treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 46 Norway cerebral infarction treatment market, by type, 2018 - 2030 (USD Billion)
  • Table 47 Norway cerebral infarction treatment market, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 48 Asia Pacific cerebral infarction treatment market, by country, 2018 - 2030 (USD Billion)
  • Table 49 Asia Pacific cerebral infarction treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 50 Asia Pacific cerebral infarction treatment market, by type, 2018 - 2030 (USD Billion)
  • Table 51 Asia Pacific cerebral infarction treatment market, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 52 Japan cerebral infarction treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 53 Japan cerebral infarction treatment market, by type, 2018 - 2030 (USD Billion)
  • Table 54 Japan cerebral infarction treatment market, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 55 China cerebral infarction treatment market, by drug class, 2018-2030 (USD Billion)
  • Table 56 China cerebral infarction treatment market, by type, 2018-2030 (USD Billion)
  • Table 57 China cerebral infarction treatment market, by distribution channel, 2018-2030 (USD Billion)
  • Table 58 India cerebral infarction treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 59 India cerebral infarction treatment market, by type, 2018 - 2030 (USD Billion)
  • Table 60 India cerebral infarction treatment market, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 61 South Korea cerebral infarction treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 62 South Korea cerebral infarction treatment market, by type, 2018 - 2030 (USD Billion)
  • Table 63 South Korea cerebral infarction treatment market, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 64 Australia cerebral infarction treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 65 Australia cerebral infarction treatment market, by type, 2018 - 2030 (USD Billion)
  • Table 66 Australia cerebral infarction treatment market, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 67 Thailand cerebral infarction treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 68 Thailand cerebral infarction treatment market, by type, 2018 - 2030 (USD Billion)
  • Table 69 Thailand cerebral infarction treatment market, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 70 Latin America cerebral infarction treatment market, by country, 2018 - 2030 (USD Billion)
  • Table 71 Latin America cerebral infarction treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 72 Latin America cerebral infarction treatment market, by type, 2018 - 2030 (USD Billion
  • Table 73 Latin America cerebral infarction treatment market, by distribution channel, 2018 - 2030 (USD Billion
  • Table 74 Brazil cerebral infarction treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 75 Brazil cerebral infarction treatment market, by type, 2018 - 2030 (USD Billion)
  • Table 76 Brazil cerebral infarction treatment market, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 77 Argentina cerebral infarction treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 78 Argentina cerebral infarction treatment market, by type, 2018 - 2030 (USD Billion)
  • Table 79 Argentina cerebral infarction treatment market, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 80 Middle East & Africa cerebral infarction treatment market, by country, 2018 - 2030 (USD Billion)
  • Table 81 Middle East & Africa cerebral infarction treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 82 Middle East & Africa cerebral infarction treatment market, by type, 2018 - 2030 (USD Billion)
  • Table 83 Middle East & Africa cerebral infarction treatment market, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 84 South Africa cerebral infarction treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 85 South Africa cerebral infarction treatment market, by type, 2018 - 2030 (USD Billion)
  • Table 86 South Africa cerebral infarction treatment market, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 87 Saudi Arabia cerebral infarction treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 88 Saudi Arabia cerebral infarction treatment market, by type, 2018 - 2030 (USD Billion)
  • Table 89 Saudi Arabia cerebral infarction treatment market, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 90 UAE cerebral infarction treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 91 UAE cerebral infarction treatment market, by type, 2018 - 2030 (USD Billion)
  • Table 92 UAE cerebral infarction treatment market, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 93 Kuwait cerebral infarction treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 94 Kuwait cerebral infarction treatment market, by type, 2018 - 2030 (USD Billion)
  • Table 95 Kuwait cerebral infarction treatment market, by distribution channel, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Cerebral infarction treatment market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Drug class outlook (USD Billion)
  • Fig. 10 Type outlook (USD Billion)
  • Fig. 11 Distribution channel outlook (USD Billion)
  • Fig. 12 Competitive landscape
  • Fig. 13 Cerebral infarction treatment market dynamics
  • Fig. 14 Cerebral infarction treatment market: Porter's five forces analysis
  • Fig. 15 Cerebral infarction treatment market: PESTLE analysis
  • Fig. 16 Cerebral infarction treatment market: Drug class segment dashboard
  • Fig. 17 Cerebral infarction treatment market: Drug class market share analysis, 2024 & 2030
  • Fig. 18 Tissue plasminogen activators (tPA) market, 2018 - 2030 (USD Billion)
  • Fig. 19 Anticoagulants market, 2018 - 2030 (USD Billion)
  • Fig. 20 Antiplatelets market, 2018 - 2030 (USD Billion)
  • Fig. 21 Anticonvulsants market, 2018 - 2030 (USD Billion)
  • Fig. 22 Others market, 2018 - 2030 (USD Billion)
  • Fig. 23 Cerebral infarction treatment market: Type segment dashboard
  • Fig. 24 Cerebral infarction treatment market: Type market share analysis, 2024 & 2030
  • Fig. 25 Ischemic stroke market, 2018 - 2030 (USD Billion)
  • Fig. 26 Hemorrhagic stroke market, 2018 - 2030 (USD Billion)
  • Fig. 27 Cerebral infarction treatment market: Distribution channel segment dashboard
  • Fig. 28 Cerebral infarction treatment market: Distribution channel market share analysis, 2024 & 2030
  • Fig. 29 Hospital pharmacies market, 2018 - 2030 (USD Billion)
  • Fig. 30 Retail pharmacies market, 2018 - 2030 (USD Billion)
  • Fig. 31 Other market, 2018 - 2030 (USD Billion)
  • Fig. 32 Cerebral infarction treatment market revenue, by region
  • Fig. 33 Regional marketplace: Key takeaways
  • Fig. 34 North America cerebral infarction treatment market, 2018 - 2030 (USD Billion)
  • Fig. 35 U.S. country dynamics
  • Fig. 36 U.S. cerebral infarction treatment market, 2018 - 2030 (USD Billion)
  • Fig. 37 Canada country dynamics
  • Fig. 38 Canada cerebral infarction treatment market, 2018 - 2030 (USD Billion)
  • Fig. 39 Mexico country dynamics
  • Fig. 40 Mexico cerebral infarction treatment market, 2018 - 2030 (USD Billion)
  • Fig. 41 Europe cerebral infarction treatment market, 2018 - 2030 (USD Billion)
  • Fig. 42 UK country dynamics
  • Fig. 43 UK cerebral infarction treatment market, 2018 - 2030 (USD Billion)
  • Fig. 44 Germany country dynamics
  • Fig. 45 Germany cerebral infarction treatment market, 2018 - 2030 (USD Billion)
  • Fig. 46 France country dynamics
  • Fig. 47 France cerebral infarction treatment market, 2018 - 2030 (USD Billion)
  • Fig. 48 Italy country dynamics
  • Fig. 49 Italy cerebral infarction treatment market, 2018 - 2030 (USD Billion)
  • Fig. 50 Spain country dynamics
  • Fig. 51 Spain cerebral infarction treatment market, 2018 - 2030 (USD Billion)
  • Fig. 52 Denmark country dynamics
  • Fig. 53 Denmark cerebral infarction treatment market, 2018 - 2030 (USD Billion)
  • Fig. 54 Sweden country dynamics
  • Fig. 55 Sweden cerebral infarction treatment market, 2018 - 2030 (USD Billion)
  • Fig. 56 Norway country dynamics
  • Fig. 57 Norway cerebral infarction treatment market, 2018 - 2030 (USD Billion)
  • Fig. 58 Asia Pacific cerebral infarction treatment market, 2018 - 2030 (USD Billion)
  • Fig. 59 Japan country dynamics
  • Fig. 60 Japan cerebral infarction treatment market, 2018 - 2030 (USD Billion)
  • Fig. 61 China country dynamics
  • Fig. 62 China cerebral infarction treatment market, 2018 - 2030 (USD Billion)
  • Fig. 63 India country dynamics
  • Fig. 64 India cerebral infarction treatment market, 2018 - 2030 (USD Billion)
  • Fig. 65 South Korea country dynamics
  • Fig. 66 South Korea cerebral infarction treatment market, 2018 - 2030 (USD Billion)
  • Fig. 67 Australia country dynamics
  • Fig. 68 Australia cerebral infarction treatment market, 2018 - 2030 (USD Billion)
  • Fig. 69 Thailand country dynamics
  • Fig. 70 Thailand cerebral infarction treatment market, 2018 - 2030 (USD Billion)
  • Fig. 71 Latin America cerebral infarction treatment market, 2018 - 2030 (USD Billion)
  • Fig. 72 Brazil country dynamics
  • Fig. 73 Brazil cerebral infarction treatment market, 2018 - 2030 (USD Billion)
  • Fig. 74 Argentina country dynamics
  • Fig. 75 Argentina cerebral infarction treatment market, 2018 - 2030 (USD Billion)
  • Fig. 76 MEA cerebral infarction treatment market, 2018 - 2030 (USD Billion)
  • Fig. 77 South Africa country dynamics
  • Fig. 78 South Africa cerebral infarction treatment market, 2018 - 2030 (USD Billion)
  • Fig. 79 Saudi Arabia country dynamics
  • Fig. 80 Saudi Arabia cerebral infarction treatment market, 2018 - 2030 (USD Billion)
  • Fig. 81 UAE country dynamics
  • Fig. 82 UAE cerebral infarction treatment market, 2018 - 2030 (USD Billion)
  • Fig. 83 Kuwait country dynamics
  • Fig. 84 Kuwait cerebral infarction treatment market, 2018 - 2030 (USD Billion)
  • Fig. 85 Company categorization
  • Fig. 86 Company market position analysis
  • Fig. 87 Strategic framework